PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Report Buyer Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

16 Million Brits Over 20 to Be Obese by 2015 Says New Report - Report Buyer, the online destination for business intelligence for major industry sectors, has now added a new report showing that by 2015, almost 16 million Britons over the age of 20 are forecast to be obese
16 Million Brits Over 20 to Be Obese by 2015 Says New Report

 

NewswireToday - /newswire/ - London, United Kingdom, 2008/02/16 - Report Buyer, the online destination for business intelligence for major industry sectors, has now added a new report showing that by 2015, almost 16 million Britons over the age of 20 are forecast to be obese.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

“Commercial and Pipeline Perspectives: Obesity, Lack of Reimbursement Limits Market Potential” reports that because of the high risk and large number of co-morbidities related with obesity, such as heart disease, stroke and diabetes, a population with a high rate of obesity represents a huge financial burden for governmental health services. Obesity is defined in most countries as someone with a body mass index (BMI) of 30 or more. The World Health Organization (WHO) estimates there to be at least 400 million clinically obese people worldwide, and the rapidly expanding epidemic shows no signs of slowing. The most rapid increase has been observed in England, where obesity rates have risen three-fold from 1980 to 2001.

The report shows that the huge rise in obesity is down to the over consumption of calories and inadequate physical activity. In practice, this is due to the increasingly sedentary nature of life in western societies combined with an increase in fast food and convenience food consumption. This is especially obvious in Japan, as the increasing westernisation of diet has led to a sharp increase in the prevalence of obesity.

However, the authors of the report note that while there are drugs on the market designed to combat obesity, the use of these drugs has not increased in line with the rise in prevalence of the disease. This is in some measure because those currently on the market are associated with unpleasant side effects. It is also due to a perceived lack of efficacy, in some part at least due to inflated expectations of weight loss on the part of the patients and unwillingness to change their lifestyle. Patients who are motivated to lose weight usually comply with treatment. However, problems commonly occur in maintaining the weight loss and behaviour modification essential to keep the excess weight off.

The study shows that the biggest barrier to widespread up-take is the lack of reimbursement. With the exception of the UK and Spain, obesity drug sales in Europe have declined in recent years, despite there being more obese people now than ever before. Despite the massive patient potential for the treatment of obesity across Europe, the size of the markets have been restricted by the lack of reimbursement and the failure to categorise obesity as a disease rather than a lifestyle condition. Conversely, the UK anti-obesity market has expanded significantly over the period of the last four years, representing 17% of the total global market. This steady growth is due to the reimbursement practices in the UK, where the patient only needs to pay the standard prescription charge for obesity medication.

The report has not identified any products in development that will provide a significant improvement to those currently available. The authors note that an especially worrying trend is that prior to the current generation, obesity has been something that largely developed in adult life. However, we are now seeing children that are essentially growing up obese, promising a huge burden for national health services and tax payers for years to come, with no immediate prospect of a 'silver bullet' cure.

“Commercial and Pipeline Perspectives: Obesity, Lack of Reimbursement Limits Market Potential” is available from Report Buyer. For more information, see website.

Report Buyer product ID: DAT04409

About Report Buyer

Report Buyer is a UK-based independent online store supplying business information. The website now carries over 44,000 business information products, including market reports, studies, books and events. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. A regularly updated blog provides information on the latest market trends.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Report Buyer Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


16 Million Brits Over 20 to Be Obese by 2015 Says New Report

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jonna Dagliden 
+44 (0) 20 7060 7474 press[.]reportbuyer.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Report Buyer Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Report Buyer Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)